Division of Gastroenterology and Hepatology News
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Gastroenterology and Hepatology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
- 07.13.2018Researchers were able to establish an etiologic diagnosis among nearly 50% of patients with previously indeterminate etiology of acute liver failure using a systematic analysis strategy that included diagnostic algorithms and expert opinion.“Indeterminate or unknown etiology of acute liver failure is established after a careful history and a series of diagnostic blood tests are still unable to identify a clear cause for the serious liver injury,” Daniel R. Ganger, MD, from the Northwestern University Feinberg School of Medicine in Chicago, told Healio Gastroenterology and Liver Disease. According to Ganger and colleagues, indeterminate ALF etiology can also often result from incomplete testing or competing diagnoses
Feinberg scientists are confronting significant, global challenges -- from antimicrobial resistance to HIV -- through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.
Northwestern faculty members have been chosen for induction into two prominent medical organizations: the American Society for Clinical Investigation and the Association of American Physicians.
A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.
- 03.03.2018"University of Chicago Medicine and Northwestern Memorial Hospital, two of the five adult liver transplant centers in Illinois, recently changed their six-month-sober policies so that select people with acute alcoholic hepatitis — a small subset of people with alcoholic liver disease — can be considered for transplants without undergoing a set period of abstinence."